These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 22835780

  • 1. Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma--a phase II trial of the childhood liver tumour strategy group (SIOPEL).
    Zsíros J, Brugières L, Brock P, Roebuck D, Maibach R, Child M, Morland B, Casanova M, Pariente D, Paris C, de Camargo B, Ronghe M, Zimmermann A, Plaschkes J, Czauderna P, Perilongo G.
    Eur J Cancer; 2012 Dec; 48(18):3456-64. PubMed ID: 22835780
    [Abstract] [Full Text] [Related]

  • 2. Irinotecan-temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial.
    Mody R, Naranjo A, Van Ryn C, Yu AL, London WB, Shulkin BL, Parisi MT, Servaes SE, Diccianni MB, Sondel PM, Bender JG, Maris JM, Park JR, Bagatell R.
    Lancet Oncol; 2017 Jul; 18(7):946-957. PubMed ID: 28549783
    [Abstract] [Full Text] [Related]

  • 3. Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee.
    Katzenstein HM, Furman WL, Malogolowkin MH, Krailo MD, McCarville MB, Towbin AJ, Tiao GM, Finegold MJ, Ranganathan S, Dunn SP, Langham MR, McGahren ED, Rodriguez-Galindo C, Meyers RL.
    Cancer; 2017 Jun 15; 123(12):2360-2367. PubMed ID: 28211941
    [Abstract] [Full Text] [Related]

  • 4. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study.
    Zsiros J, Brugieres L, Brock P, Roebuck D, Maibach R, Zimmermann A, Childs M, Pariente D, Laithier V, Otte JB, Branchereau S, Aronson D, Rangaswami A, Ronghe M, Casanova M, Sullivan M, Morland B, Czauderna P, Perilongo G, International Childhood Liver Tumours Strategy Group (SIOPEL).
    Lancet Oncol; 2013 Aug 15; 14(9):834-42. PubMed ID: 23831416
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Relapses in hepatoblastoma patients: clinical characteristics and outcome--experience of the International Childhood Liver Tumour Strategy Group (SIOPEL).
    Semeraro M, Branchereau S, Maibach R, Zsiros J, Casanova M, Brock P, Domerg C, Aronson DC, Zimmermann A, Laithier V, Childs M, Roebuck D, Perilongo G, Czauderna P, Brugieres L.
    Eur J Cancer; 2013 Mar 15; 49(4):915-22. PubMed ID: 23146961
    [Abstract] [Full Text] [Related]

  • 7. Dramatic response of multiply relapsed hepatoblastoma to irinotecan (CPT-11).
    Palmer RD, Williams DM.
    Med Pediatr Oncol; 2003 Jul 15; 41(1):78-80. PubMed ID: 12764754
    [No Abstract] [Full Text] [Related]

  • 8. Carboplatin-epirubicin regimen for the treatment of hepatoblastoma.
    Blouin P, Brugières L, Tabone MD, Leverger G, Rubie H, Branchereau S, De Kraker J.
    Pediatr Blood Cancer; 2004 Feb 15; 42(2):149-54. PubMed ID: 14752879
    [Abstract] [Full Text] [Related]

  • 9. Hepatoblastoma presenting with lung metastases: treatment results of the first cooperative, prospective study of the International Society of Paediatric Oncology on childhood liver tumors.
    Perilongo G, Brown J, Shafford E, Brock P, De Camargo B, Keeling JW, Vos A, Philips A, Pritchard J, Plaschkes J.
    Cancer; 2000 Oct 15; 89(8):1845-53. PubMed ID: 11042582
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study.
    Zsíros J, Maibach R, Shafford E, Brugieres L, Brock P, Czauderna P, Roebuck D, Childs M, Zimmermann A, Laithier V, Otte JB, de Camargo B, MacKinlay G, Scopinaro M, Aronson D, Plaschkes J, Perilongo G.
    J Clin Oncol; 2010 May 20; 28(15):2584-90. PubMed ID: 20406943
    [Abstract] [Full Text] [Related]

  • 13. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B, Bode U, von Schweinitz D.
    Klin Padiatr; 2003 May 20; 215(3):159-65. PubMed ID: 12778356
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group.
    O'Neill AF, Towbin AJ, Krailo MD, Xia C, Gao Y, McCarville MB, Meyers RL, McGahren ED, Tiao GM, Dunn SP, Langham MR, Weldon CB, Finegold MJ, Ranganathan S, Furman WL, Malogolowkin M, Rodriguez-Galindo C, Katzenstein HM.
    J Clin Oncol; 2017 Oct 20; 35(30):3465-3473. PubMed ID: 28892430
    [Abstract] [Full Text] [Related]

  • 16. Guidelines for surgical treatment of hepatoblastoma in the modern era--recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL).
    Czauderna P, Otte JB, Aronson DC, Gauthier F, Mackinlay G, Roebuck D, Plaschkes J, Perilongo G, Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL).
    Eur J Cancer; 2005 May 20; 41(7):1031-6. PubMed ID: 15862752
    [Abstract] [Full Text] [Related]

  • 17. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.
    Wessalowski R, Schneider DT, Mils O, Friemann V, Kyrillopoulou O, Schaper J, Matuschek C, Rothe K, Leuschner I, Willers R, Schönberger S, Göbel U, Calaminus G, MAKEI study group.
    Lancet Oncol; 2013 Aug 20; 14(9):843-52. PubMed ID: 23823158
    [Abstract] [Full Text] [Related]

  • 18. A phase II study of irinotecan with biweekly, low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFIRI) as first line therapy for patients with recurrent or metastatic gastric cancer.
    Kim BG, Oh SY, Kwon HC, Lee S, Lee DM, Kim SG, Kim DK, Jang JS, Kim MC, Kim SH, Kim HJ.
    Am J Clin Oncol; 2010 Jun 20; 33(3):246-50. PubMed ID: 19770628
    [Abstract] [Full Text] [Related]

  • 19. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group.
    Schnater JM, Aronson DC, Plaschkes J, Perilongo G, Brown J, Otte JB, Brugieres L, Czauderna P, MacKinlay G, Vos A.
    Cancer; 2002 Feb 15; 94(4):1111-20. PubMed ID: 11920482
    [Abstract] [Full Text] [Related]

  • 20. Novel therapeutic approaches in the treatment of children with hepatoblastoma.
    Katzenstein HM, Rigsby C, Shaw PH, Mitchell TL, Haut PR, Kletzel M.
    J Pediatr Hematol Oncol; 2002 Dec 15; 24(9):751-5. PubMed ID: 12468918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.